Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312625 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hong Kyung Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Chungbuk National University, Chungbuk 28160, Republic of Korea. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Mesenchymal Stem Cells, B-Lymphocytes, Diterpenes. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine.
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by autoantibody production by hyper-activated B cells. Although mesenchymal stem cells (MSCs) relieve lupus symptoms by inhibiting mainly T cells, whether MSCs also inhibit B cells has been controversial. Here, we found that naïve MSCs inhibited IFN-γ production by T cells, but not IgM production by B cells. We used a chemical approach to prime MSCs to inhibit B cells. We found that ingenol-3-angelate (I3A), a non-tumor-promoting phorbol ester, activated MSCs to inhibit B cells in a TGF-β1-dependent manner. We also showed that IL-1β induced MSCs to continuously secrete TGF-β1, which directly inhibited IgM production by B cells, whereas IL-1β did not. I3A-treated MSCs were better than naïve MSCs at ameliorating SLE symptoms in MRL.faslpr mice. In summary, our data provide information on how to generate MSCs that are effective for the treatment of SLE characterized by excessive B cell activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Chungbuk National University, Chungbuk 28160, Republic of Korea.
- Bioengineering Institute, CorestemChemon Inc., Gyeonggi 13486, Republic of Korea.
ORCID-Profile: Ji Yeon Kim, Dong Ju Son, Jin Tae Hong, Sang-Bae Han
Förderung
- National Research Foundation of Korea
- Korean Fund for Regenerative Medicine
Zitieren
APA
Lee, H. K., Kim, H. K., Kim, J. Y., Kim, J. S., Park, J., Kim, M. S., Lee, T. Y., Lim, K. H., Park, H., Son, D. J., Hong, J. T., & Han, S. B. (2024). Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312625
Vancouver
Lee HK, Kim HK, Kim JY, Kim JS, Park J, Kim MS, et al. Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312625
BibTeX
@article{Lee2024,
author = {Lee, Hong Kyung and Kim, Hwa Kyung and Kim, Ji Yeon and Kim, Ji Su and Park, JinKyung and Kim, Min Sung and Lee, Tae Yong and Lim, Key-Hwan and Park, Hanseul and Son, Dong Ju and Hong, Jin Tae and Han, Sang-Bae},
title = {Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312625}
}
EUVIMED